Autopsy report · NCT02619617
Safety and Efficacy Study of SOM230 s.c. in Cluster Headache
Cause of deathOther
“Novartis decision based on Cohort 1 results”
Life of this trial
- Registered 11 months before it started.
- Ran for about 1 year 11 months before it stopped.
- 28 participants enrolled.
- Results were posted on the registry 1 year 4 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2
- Sponsor
- Novartis Pharmaceuticals
- Sponsor type
- Industry
- Conditions
- Cluster Headache - Episodic and Chronic
- Interventions
- SOM230; Placebo
- Participants
- 28
- Sites
- 4
- Countries
- Germany, United Kingdom, United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.